Robert Herring

5.8k citations
25 papers · 4.5k · 6 hit papers · h-index 13

Impact in

  • Hepatology top 0.2%
    • Hepatitis C virus research
    • Liver physiology and pathology
    • Liver Diseases and Immunity
    • Hepatocellular Carcinoma Treatment and Prognosis
    • Liver Disease Diagnosis and Treatment

Papers in

Robert Herring

25 papers receiving 4.4k citations

Robert Herring's Hit Papers

Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial 2022 · 192 citations
1920+4+8Years since publication2505007501k

Peers

Robert Herring
Comparison fields: 5 of 76
  • Hepatology 2.5k
  • Epidemiology 1.6k
  • Oncology 236
  • Pharmacology 54
  • Molecular Biology 257
Replace Ziad H Younes with:
Ziad H Younes United States
Mihály Makara Hungary
Kelly Kaita Canada
Stephen Pianko Australia
Ewa Janczewska Poland
Humberto I. Aguilar United States
David Pound United States
Parvez Mantry United States
Edward Tam Canada
Victor Ankoma‐Sey United States
Robert Herring relative to Ziad H Younes United States Ziad H Younes's profile →
Citations per field
00.5×1.5×
Ziad H Younes · 1×
Citations per year

Countries citing papers authored by Robert Herring

Since Specialization
Citations

This map shows the geographic impact of Robert Herring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Herring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Herring more than expected).

Fields of papers citing papers by Robert Herring

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Herring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Herring. The network helps show where Robert Herring may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert Herring, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert Herring Line = papers co-authored together Robert Herring links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
Hit paper breakdown →
20141121
2
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Hit paper breakdown →
20191078
3
Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
Hit paper breakdown →
2014980
4
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
Hit paper breakdown →
2020414
5
Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial
Hit paper breakdown →
2020301
6
Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial
Hit paper breakdown →
2022192
7 2015112
8 202076
9 201649
10 201244
11 201340
12 201239
13 200422
14 201212
15 201611
16 201811
17 201910
18 20199
19 20108
20 20124

About Robert Herring

Robert Herring is a scholar working on Hepatology, Epidemiology, Toxicology, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 25 papers that have together received 4.5k indexed citations. Recurring topics across this work include Hepatitis C virus research (16 papers), Liver Disease Diagnosis and Treatment (10 papers) and Pharmacovigilance and Adverse Drug Reactions (1 paper). The work is most often cited by research in Hepatology (2.5k citations), Epidemiology (1.6k citations), Oncology (236 citations), Pharmacology (54 citations) and Molecular Biology (257 citations). Robert Herring has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Tarek Hassanein, Zeid Kayali, Mazen Noureddin, Rohit Seth Loomba, Robert P. Myers, Maribel Rodriguez‐Torres, Yanni Zhu, Andrew N. Billin, Clare A. Balendran and L.H. Damgaard. Their work appears in journals such as Journal of Hepatology, New England Journal of Medicine, Hepatology, The Lancet and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact